Journals recently featuring the work of University of Arizona Cancer Center members:
Dietary Supplements and Cancer Prevention: Balancing Potential Benefits Against Proven Harms
Journal of the National Cancer Institute, April 25, 2012
Phase I trial of intraperitoneal pemetrexed, cisplatin, and paclitaxel in optimally debulked ovarian cancer
Clinical Cancer Research, March 15, 2012
Molecular Pathways: The Role of Primary Cilia in Cancer Progression and Therapeutics with a Focus on Hedgehog Signaling
Clinical Cancer Research, March 13, 2012
Aurora A inhibitor (MLN8237) plus Vincristine synergizes with Rituximab as a potential curative therapy in aggressive B-cell non-Hodgkin lymphoma
Clinical Cancer Research, Feb. 28, 2012
Imexon Induces an Oxidative Endoplasmic Reticulum Stress Response in Pancreatic Cancer Cells
Molecular Cancer Research, Jan. 24, 2012
Demonstration that Drug-targeted Down-regulation of MYC in Non-Hodgkins Lymphoma Is Directly Mediated through the Promoter G-quadruplex*
The Journal of Biological Chemistry, Nov. 25, 2011
Th-1 Lymphocytes Induce Dendritic Cell Tumor Killing Activity by an IFN-γ–Dependent Mechanism
The Journal of Immunology, Nov. 9, 2011
Acquisition of resistance towards HYD1 correlates with a reduction in cleaved alpha 4 integrin expression and a compromised CAM-DR phenotype
Molecular Cancer Theraputics, Oct. 6, 2011
Understanding the dual nature of CD44 in breast cancer progression
Molecular Cancer Research, Oct. 4, 2011
Macrophage Dependent Cleavage of the Laminin Receptor α6β1 in Prostate Cancer
Molecular Cancer Research, Aug. 8, 2011
Cytotoxic Dendritic Cells Generated from Cancer Patients
The Journal of Immunology, July 29, 2011
E-mail this page
